Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASH 2014 /
Should young adults with acute lymphocytic leukaemia receive paediatric treatment protocols?

6th - 9th Dec 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.12.14
Views: 3156
Rating:

Dr Wendy Stock - University of Chicago, Chicago, USA

Dr Wendy Stock talks to ecancertv at ASH 2014 about the use of paediatric treatment regimens to improve outcomes in young adults with acute lymphocytic leukaemia.

Patients characterised as 'adolescents' or 'young adults' often receive treatment tailored for adult patients. However, Dr Stock notes, these patients improve under regimens designed for children.

Watch the press conference and read the news story for more.

ecancer's filming at ASH 2014 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation